Example: Heart Attack

Search clinical trials for: 68Ga-FAPI-RGD

Total 2493 results

NCT06369831

Recruiting

HER2 Targeted Molecular Imaging in mBC and Other Metastatic Solid Carcinomas Using 68Ga-ABS011 (HERMIA)

Metastatic Breast Cancer | Metastatic Solid Cancer
NCT02978196

Completed

99mTc/68Ga Labeled Anti-PD-L1 sdAb in Assessment of PD-L1 Expression in NSCLC

Non-Small Cell Lung Cancer
NCT00094276

Completed

Intervention for Improving Asthma Care for Minority Children in Head Start

Lung Diseases | Asthma
NCT07434180

Not yet recruiting

Phase II Trial of Lu-177 FAP-2286 in Patients With Carcinoma of Unknown Primary (Lu-FAP CUP)

Cancer of Unknown Primary
NCT07069725

Recruiting

The Phase 1, Open-label, PET Trial Designed to Investigate the Effect of AZD2389 on FAP Occupancy in the Liver in Participants With Advanced Liver Fibrosis. (PECHORA)

Liver Fibrosis | Hepatic Cirrhosis
NCT05752097

Recruiting

[18F]AlF-NOTA-FAPI-04 PET/CT in Inflammation and Fibrosis in Renal Diseases

18F-FAPI PET/CT Examination | Renal Puncture Biopsy
NCT06769893

Recruiting

A Study Evaluating the Value of 68Ga-NOTA-RCCB6 PET Imaging for Targeting CD70 in the Clinical Staging, Therapeutic Evaluation, and Restaging of Renal Cell Carcinoma, and Comparing It with 68Ga-PSMA PET/CT Imaging

RCC, Renal Cell Cancer
NCT06246357

Recruiting

Evaluating the Functional Status of the Adrenal Glands With [68Ga]Ga-PentixaFor in Hyperaldosteronism and Hypercortisolism

Hyperaldosteronism | Hypercortisolism | Cushing s Syndrome
NCT04043377

Terminated

68Ga-DOTATATE PET-CTA Imaging for the Early Detection of Progressing Coronary Atherosclerosis (iPROGRESS)

Coronary Arteriosclerosis
NCT02559115

Completed

68Ga-RM2 for PET/CT of Gastrin Releasing Peptide Receptor (GRPr) Expression in Prostate Cancer

Prostate Cancer
NCT02967666

Unknown

Evaluation of PET/MRI Using a Somatostatin Analog Tracer as a Novel Approach to Detecting Pathology in High Risk TB-exposed Contacts

Tuberculosis, Pulmonary
NCT06389123

Recruiting

Molecularly Targeted Theranostic Approach for the Detection and Treatment of Metastatic Carcinomas

Metastatic Cancer
NCT02624518

Completed

68Ga-RM2 PET/MRI in Biochemically Recurrent Prostate Cancer

Prostate Adenocarcinoma
NCT06562361

Recruiting

A Microdose Trial Investigating Binding of [68Ga]Ga-DOTA-CYS-ATH001 in Healthy Subjects and Different Patient Groups.

Healthy Volunteers | PSC | Fibrostenotic Crohn's Disease | MASH
NCT04169321

Completed

Granzyme B PET Imaging Drug as a Predictor of Immunotherapy Response to Checkpoint Inhibitors

Lymphoma | Solid Tumor, Unspecified, Adult
NCT02960724

Unknown

uPAR PET/CT for Staging Advanced and Localised Oral and Oropharyngeal Cancer

Neoplasms | Neoplasms by Site | Head and Neck Neoplasms | Oral Cancer | Oropharyngeal Cancer | Cancer of Mouth
NCT01676103

Completed

The Effects of Supplementing Tyrosine on Blood Pressure in Parkinson's Disease

Parkinson's Disease
NCT04685811

Completed

Evaluation of PSMA Antagonist Produced by Two Different Methods

Metastatic Prostate Adenocarcinoma
NCT03271281

Completed

PET/CT Imaging of Angiogenesis in Patients With Neuroendocrine Tumors Using 68Ga-NODAGA-E[c(RGDyK)]2

Neuroendocrine Tumors
NCT02389101

Completed

Molecular and Whole-body MR Imaging in Lymphomas (MILY)

Lymphoma | Lymphoma, Non-Hodgkin | Hodgkin Disease
NCT07099391

Recruiting

A Study of Dara-RVd and Teclistamab-RVd in People With Multiple Myeloma

Multiple Myeloma
NCT06911489

Recruiting

Safety Trial of 68Ga/177Lu-NRT6020 in FAP-Positive Advanced Solid Tumor Patients

Solid Tumor Malignancy
NCT04938193

Recruiting

68Ga-citrate PET/CT for the Diagnosis of Chronic Prosthetic Hip or Knee Infection (Gal-I-TEP)

Prosthetic Joint Infection
NCT03335280

Terminated

68Ga-citrate PET/MR Imaging for Glioma

Glioma
NCT02916394

Unknown

In Vivo IGF-1R Molecular Imaging Using [68Ga]- Labelling Anti-IGF-1R Affibody Molecule

Molecular Imaging
NCT06553846

Not yet recruiting

A Clinial Trial of Lutetium [177Lu]-FAP-75 for the Treatment of Patients With Advanced Solid Tumors

Solid Tumors
NCT03766360

Unknown

Bariatric Surgery Study (SIBS)

Depression | Quality of Life | Interpersonal Relations
NCT00605709

Withdrawn

Dose-Ranging Safety and Efficacy Study of Topical Creams Containing API 31510 for the Treatment of in Situ Cutaneous Squamous Cell Carcinoma

Squamous Cell Carcinoma
NCT06462508

Recruiting

Head-to-head Comparison of [18F]F-PSMA-N5 With [68Ga]Ga-PSMA-11 PET/CT in PCa Diagnosis, Recurrence, and Metastasis

Prostate Cancer | PET/CT
NCT04886986

Recruiting

Phase I Study of 225Ac-J591 Plus 177Lu-PSMA Small Molecule for Progressive Metastatic Castration Resistant Prostate Cancer

Prostate Cancer
NCT02483884

Terminated

PET/CT Imaging Study of the Safety and Diagnostic Performance of [68Ga]RM2 in Patients With Primary Prostate Cancer

Prostate Cancer
NCT05034783

Active, not recruiting

[68Ga]Ga-HBED-CC-exendin-4 and [68Ga]Ga-NOTA-exendin-4 PET/CT Imaging in the Same Group of Insulinoma Patients

Insulinoma
NCT05605522

Terminated

A Study of [225Ac]-FPI-2059 in Adult Participants With Solid Tumours

Gastric Cancer | Colorectal Cancer | Ewing Sarcoma | Squamous Cell Carcinoma of Head and Neck | Pancreatic Ductal Adenocarcinoma (PDAC) | NTSR1 Expressing Solid Tumours | Neuroendocrine Differentiated (NED) Prostate Cancer
NCT05788874

Not yet recruiting

Study of 18F-FAPI Applied to Gastrointestinal Cancer

Gastrointestinal Cancer
NCT03809078

Completed

68Ga PSMA 11 PET/MRI and 68Ga RM2 PET/MRI for Biopsy Guidance in Patients With Suspected Prostate Cancer

Prostate Cancer
NCT03187990

Completed

Positron Emission Tomography / Magnetic Resonance Imaging (PET/MRI) Guided Biopsy in Men With Elevated PSA

Prostate Cancer
NCT06228482

Recruiting

Molecularly Targeted Radionuclide Therapy Via the Integrin Alphavbeta6

Metastatic Nonsmall Cell Lung Cancer
NCT00928083

Completed

A Study to Investigate the Safety, Tolerability and Pharmacokinetics of OZ439 in Healthy Male and Female Subjects

Healthy Volunteers | Malaria Falciparum | Malaria Vivax
NCT03843476

Withdrawn

Personalized Spine Study Group Registry

Degenerative Disc Disease | Spinal Stenosis | Spinal Fusion | Kyphoscoliosis | Scoliosis; Adolescence | Pseudoarthrosis of Spine | Kyphoses, Scheuermann
NCT01546350

Suspended

Preimplantation Genetic Diagnosis Using Blastocyst Biopsy and Array CGH

Infertility | Recurrent Pregnancy Loss
NCT00988936

Completed

Efficacy Study of [F-18]RGD-K5 Positron Emission Tomography (PET) as a Tool to Monitor Response to an Anti-angiogenic Drug (K5-101)

Non-squamous Non-small Cell Lung Cancer | Metastatic Breast Cancer | Metastatic Colon/Rectum Cancer
NCT05643222

Completed

Performance of Red Tinted Contact Lenses on Colour Defects (CL)

Color Vision Defects | Color Blindness
NCT01223118

Completed

Evaluation of the Impact of Vitrification on Oocytes

Fertilization
NCT07510321

Recruiting

FL-261 Imaging for Cancer Diagnosis and Staging

Colorectal Cancer | Non-Small Cell Lung Cancer | Advanced Solid Tumors | Head & Neck Cancer
NCT07076550

Recruiting

A Phase 1-1b Study to Evaluate the Safety, Efficacy and Dosimetry of Study Drug A9-3408 in Subjects With Metastatic Melanoma

Mucosal Melanoma | Melanoma Metastatic | Uveal Melanoma, Metastatic
NCT00000322

Completed

Tyrosine for Methamphetamine Dependence - 1

Amphetamine-Related Disorders
NCT07516288

Not yet recruiting

Safety and Efficacy of Second Infusion of FAP iCDC in End-stage Dilated Cardiomyopathy

Heart Failure | Dilated Cardiomyopathy (DCM)
NCT05516121

Completed

VLT-015 in Patients With Schizophrenia (VLT-015)

Schizophrenia
NCT04665947

Recruiting

First-in-human Study of the Theranostic Pair [68Ga]Ga DOTA-5G and [177Lu]Lu DOTA-ABM-5G in Pancreatic Cancer

Locally Advanced Pancreatic Adenocarcinoma | Metastatic Pancreatic Cancer
NCT06478875

Not yet recruiting

Evaluation of [68Ga]Ga-PentixaFor PET Imaging for the Identification of Unilateral Adrenal Secretion of ALdosterON in Patients With Primary Aldosteronism (PENTALON)

Primary Aldosteronism

Search clinical trials for: 68Ga-FAPI-RGD

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations